Benidipine suppresses in situ proliferation of leukocytes and slows the progression of renal fibrosis in rat kidneys with advanced chronic renal failure.

Nephron Experimental Nephrology Pub Date : 2014-01-01 Epub Date: 2014-10-24 DOI:10.1159/000368080
Itsuro Kazama, Asuka Baba, Mitsunobu Matsubara, Yasuhiro Endo, Hiroaki Toyama, Yutaka Ejima
{"title":"Benidipine suppresses in situ proliferation of leukocytes and slows the progression of renal fibrosis in rat kidneys with advanced chronic renal failure.","authors":"Itsuro Kazama,&nbsp;Asuka Baba,&nbsp;Mitsunobu Matsubara,&nbsp;Yasuhiro Endo,&nbsp;Hiroaki Toyama,&nbsp;Yutaka Ejima","doi":"10.1159/000368080","DOIUrl":null,"url":null,"abstract":"<p><strong>Background/aims: </strong>Leukocytes, such as lymphocytes and macrophages, predominantly express delayed rectifier K(+) channels (Kv1.3) in their plasma membranes. In our previous study, the overexpression of these channels in leukocytes was strongly associated with their proliferation in kidneys and the progression of renal fibrosis in advanced-stage chronic renal failure (CRF). Since benidipine, a long-acting 1,4-dihydropyridine Ca(2+) channel blocker, is also highly potent as a Kv1.3 channel inhibitor, it could exert therapeutic efficacy in advanced CRF.</p><p><strong>Methods: </strong>Male Sprague-Dawley rats that underwent 5/6 nephrectomy followed by a 14-week recovery period were used as the model of advanced CRF. Benidipine hydrochloride (5 mg/kg) was started at 8 weeks after nephrectomy and orally administered daily for 6 weeks. The histopathological features of the kidneys were examined in vehicle-treated and benidipine-treated CRF rat kidneys. Cellular proliferation of leukocytes and the cortical expression of proinflammatory cytokines were also examined.</p><p><strong>Results: </strong>In CRF rat kidneys, Kv1.3 channels began to be overexpressed in leukocytes as early as 8 weeks after nephrectomy. In the cortical interstitium of benidipine-treated CRF rat kidneys, both immunohistochemistry and real-time PCR demonstrated decreased expression of fibrotic markers. Benidipine treatment significantly reduced the number of proliferating leukocytes within the cortical interstitium and decreased the expression of cell cycle markers and proinflammatory cytokines.</p><p><strong>Conclusion: </strong>This study demonstrated for the first time that benidipine slowed the progression of renal fibrosis in rat kidneys with advanced CRF. Kv1.3 channels overexpressed in leukocytes were thought to be the most likely therapeutic targets of benidipine in decreasing the number of proliferating leukocytes and repressing the production of inflammatory cytokines.</p>","PeriodicalId":18993,"journal":{"name":"Nephron Experimental Nephrology","volume":"128 1-2","pages":"67-79"},"PeriodicalIF":0.0000,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000368080","citationCount":"20","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nephron Experimental Nephrology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1159/000368080","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2014/10/24 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 20

Abstract

Background/aims: Leukocytes, such as lymphocytes and macrophages, predominantly express delayed rectifier K(+) channels (Kv1.3) in their plasma membranes. In our previous study, the overexpression of these channels in leukocytes was strongly associated with their proliferation in kidneys and the progression of renal fibrosis in advanced-stage chronic renal failure (CRF). Since benidipine, a long-acting 1,4-dihydropyridine Ca(2+) channel blocker, is also highly potent as a Kv1.3 channel inhibitor, it could exert therapeutic efficacy in advanced CRF.

Methods: Male Sprague-Dawley rats that underwent 5/6 nephrectomy followed by a 14-week recovery period were used as the model of advanced CRF. Benidipine hydrochloride (5 mg/kg) was started at 8 weeks after nephrectomy and orally administered daily for 6 weeks. The histopathological features of the kidneys were examined in vehicle-treated and benidipine-treated CRF rat kidneys. Cellular proliferation of leukocytes and the cortical expression of proinflammatory cytokines were also examined.

Results: In CRF rat kidneys, Kv1.3 channels began to be overexpressed in leukocytes as early as 8 weeks after nephrectomy. In the cortical interstitium of benidipine-treated CRF rat kidneys, both immunohistochemistry and real-time PCR demonstrated decreased expression of fibrotic markers. Benidipine treatment significantly reduced the number of proliferating leukocytes within the cortical interstitium and decreased the expression of cell cycle markers and proinflammatory cytokines.

Conclusion: This study demonstrated for the first time that benidipine slowed the progression of renal fibrosis in rat kidneys with advanced CRF. Kv1.3 channels overexpressed in leukocytes were thought to be the most likely therapeutic targets of benidipine in decreasing the number of proliferating leukocytes and repressing the production of inflammatory cytokines.

贝尼地平抑制晚期慢性肾功能衰竭大鼠肾脏中白细胞原位增殖并减缓肾纤维化进展。
背景/目的:白细胞,如淋巴细胞和巨噬细胞,主要在质膜上表达延迟整流K(+)通道(Kv1.3)。在我们之前的研究中,白细胞中这些通道的过表达与它们在肾脏中的增殖和晚期慢性肾功能衰竭(CRF)中肾纤维化的进展密切相关。贝尼地平作为长效1,4-二氢吡啶类Ca(2+)通道阻滞剂,也是高效的Kv1.3通道抑制剂,可能在晚期CRF中发挥疗效。方法:采用5/6肾切除术后恢复期14周的雄性Sprague-Dawley大鼠作为晚期肾衰模型。盐酸苯尼地平(5 mg/kg)于肾切除术后8周开始,每日口服,连续6周。用药物处理和苯尼地平处理的CRF大鼠肾脏,观察肾脏的组织病理学特征。白细胞的增殖和促炎细胞因子的皮质表达也被检测。结果:在CRF大鼠肾脏中,Kv1.3通道早在肾切除术后8周就开始在白细胞中过表达。在贝尼地平处理的CRF大鼠肾脏皮质间质中,免疫组织化学和实时PCR均显示纤维化标志物的表达降低。贝尼地平治疗显著降低皮质间质内增殖白细胞的数量,降低细胞周期标志物和促炎细胞因子的表达。结论:本研究首次证实,贝尼地平可减缓晚期慢性肾功能衰竭大鼠肾纤维化的进展。白细胞中过表达的Kv1.3通道被认为是苯尼地平减少增殖白细胞数量和抑制炎症细胞因子产生的最有可能的治疗靶点。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Nephron Experimental Nephrology
Nephron Experimental Nephrology 医学-泌尿学与肾脏学
自引率
0.00%
发文量
0
审稿时长
>12 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信